Introduction. Although there has been a growing concern over the possible damaging effect of salpingectomy on ovarian reserve, this issue remains uncertain. The purpose of this meta-analysis was to test the hypothesis that salpingectomy may compromise ovarian reserve. Material and methods. A detailed search was conducted using MEDLINE, Embase, Dynamed Plus, ScienceDirect, TRIP database and the Cochrane Library from January 2000 to November 2016. All cohort, cross-sectional and randomized controlled studies investigating changes in circulating anti-M€ ullerian hormone (AMH) after salpingectomy were considered. Thirty-seven studies were identified, of which eight were eligible. Data were extracted and entered into REVMAN software for calculation of the weighted mean difference (WMD) and 95% CI. Two groups of studies were analyzed separately: group 1 (six studies, n = 464) comparing data before and after salpingectomy and group 2 (two studies) comparing data in women who have undergone salpingectomy (n = 169) vs. healthy controls (n = 154). Results. Pooled results of group 1 studies showed no statistically significant change in serum AMH concentration after salpingectomy (WMD, À0.10 ng/mL; 95% CI À0.19 to 0.00, I 2 = 0%). Similarly, meta-analysis of group 2 showed no statistically significant difference in serum AMH concentration between salpingectomy group and controls (WMD, À0.11 ng/ mL; 95% CI À0.37 to 0.14, I 2 = 77%). Subgroup analyses based on laterality of surgery, type of AMH kit and participants' age (<40 years) still showed no statistically significant changes in circulating AMH. Conclusion. Salpingectomy does not seem to compromise ovarian reserve in the short-term. However, the long-term effect of salpingectomy on ovarian reserve remains uncertain.
Introduction
Since its introduction by Lawson Tait in 1883, salpingectomy has been one of the most commonly performed surgical procedures in gynecological practice worldwide (1) . Common indications include ectopic pregnancy and salpingitis (for example symptomatic hydro-or pyo-salpinx). More recently, it has been widely accepted that
Key Message
This meta-analysis investigates the possible damaging effect of salpingectomy on ovarian reserve. The results confirmed the short-term safety of salpingectomy with no effect on circulating anti-M€ ullerian hormone, which is the main marker of ovarian reserve. salpingectomy should be offered to women with asymptomatic hydrosalpinx who require in vitro fertilization (IVF) (2) . Moreover, with emerging evidence suggesting a tubal origin for ovarian cancer, salpingectomy is increasingly performed during hysterectomy in women conserving their ovaries (3, 4) .
This rising trend in salpingectomy has been associated with a rising concern over its potentially damaging effect on ovarian reserve due to possible concomitant damage of ovarian blood supply given the close proximity of tubal and ovarian arteries. It has therefore been hypothesized that salpingectomy could interrupt ovarian blood supply, thereby compromising ovarian blood flow with a consequent decline in ovarian reserve. This hypothesis is supported by a previous study showing post-salpingectomy impairment of the ovarian blood flow on the operated side (5) . Another study detected an increase in vascular resistance in ovarian arteries following Filshie clip sterilization (6) .
As most women requiring salpingectomy are relatively young and still wishing to preserve their fertility potential, it will be critical to evaluate any possible impairment of their ovarian reserve. This will help both the clinician and the patient when considering the need for salpingectomy.
Although there are numerous markers for ovarian reserve, it is now universally agreed that circulating anti-M€ ullerian hormone (AMH) is considered the most reliable test. It has been found to correlate well with the actual histological count of the ovarian follicles (7) . Furthermore, the stability of serum AMH level throughout the menstrual cycle with minimal variations makes it an ideal marker for detecting relatively small changes in ovarian reserve following salpingectomy (8) .
To date, there are several studies evaluating the effect of salpingectomy on ovarian reserve (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Given the small size of these studies, further evidence is required to address this important topic. This meta-analysis was therefore designed to investigate the impact of salpingectomy on ovarian reserve as determined by serum AMH concentrations.
Material and methods
This analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines (23) and was registered in PROSPERO (Registration number: CRD42016052576).
Eligibility criteria
We considered all published cohort (retrospective and prospective) and cross-sectional studies as well as randomized controlled trials (RCTs) that investigated changes in serum AMH levels following salpingectomy.
Outcome measures
Primary measure. This included changes in the serum AMH concentration after salpingectomy.
Secondary measures. This included changes in serum follicle-stimulating hormone (FSH) concentration and antral follicle count (AFC) after salpingectomy.
Search strategy
A detailed electronic search was conducted using numerous databases from January 2000 to November 2016 to identify available research articles investigating the effect of salpingectomy on ovarian reserve as estimated by changes in serum AMH levels (see Supplementary material, Table S1 ). Searched databases included MEDLINE, Embase, Dynamed Plus, ScienceDirect, TRIP database, and the Cochrane Library. Medical Subject Headings (MeSH) terms used included: Salpingectomy, Ovarian Function, Ovarian Reserve, Pregnancy, Laparoscopy, Laparotomy, Anti-M€ ullerian Hormone, Follicle-Stimulating Hormone, and Fertility. Keywords searched included: Antral Follicle Count, Bilateral Salpingectomy, and Unilateral Salpingectomy. Papers were limited to the English language, human studies and adult females. All searches were conducted by the first author (AM) and then independently repeated using the same criteria by an accredited clinical librarian (CJ). All related reports were retrieved, and their reference lists were revised manually to categorize further studies. We also considered published abstracts from conferences.
Study selection
Two investigators (AM, AY) independently screened the title and abstract of all identified articles to assess relevance to our meta-analysis. In case of disagreement, the full text was retrieved and reviewed independently by another author (SA) for a final decision.
Data extraction
All retrieved articles were assessed according to a standardized format including; study design, methods, participant characteristics, intervention, and results. Two investigators (AM and AY) scored the studies and collected the information independently. In the case of discrepancies in scoring between the two investigators, a consensus was reached after discussion or after involvement of the senior investigator (SA). In five studies, the mean AE SD AMH serum concentration was missing (11, (19) (20) (21) (22) . Two authors provided the missing data (mean AE SD AMH, type of AMH kit and mean AE SD age of participants) when contacted by email (11, 21) The author of another study was not contactable (20) . Authors of the remaining two studies were contacted by email, but no response was received (19, 22) .
Quality of included studies and risk of bias assessment
Modified Newcastle-Ottawa scale was used for assessing the quality and risk of bias of the included studies. Each article was scored according to three categories including selection (maximum three stars), comparability (four stars), and outcomes (two stars) (24, 25) . Selection was rated according to recruitment bias, selection of consecutive women and power calculation. Comparability was assessed based on adjustment of analysis for four confounders including women's age (<40 years), baseline serum AMH (≥3.1 ng/mL), laterality of surgery and associated hysterectomy. Outcome was scored according to completeness of at least a 3-month follow up after surgery. In the current analysis, we have given more weight to comparability factors and used the cut-off level of six stars with a minimum of three stars in the comparability category (24, 25) . Table 1 shows the results of quality scores of the studies included in this analysis.
Data analysis
This meta-analysis included two groups of studies. Group 1 involved studies comparing changes of outcomes (AMH, FSH, AFC) before and after salpingectomy. Group 2 included studies comparing outcomes between women who had undergone salpingectomy vs. healthy controls. In both groups, mean AE SD serum AMH and FSH concentrations and AFC were extracted from the individual studies and pooled using REVMAN software (REVIEW MANAGER, version 5.1, The Cochrane Collaboration, 2011; The Nordic Cochrane Center, Copenhagen, Denmark). The weighted mean difference (WMD) was calculated in both groups. Statistical heterogeneity was assessed by chisquared test and I 2 statistics. A chi-squared statistic larger than its degree of freedom or an I 2 > 50% was indicative of significant heterogeneity between studies. When heterogeneity was significant, a random-effect model was used for meta-analysis. Fixed effect meta-analysis was used when there was no significant heterogeneity.
The initial analyses included data from all studies in both groups. Further subgroup analyses of AMH levels were then performed based on the laterality of the excised fallopian tube, AMH kits and age of participants.
Results
Thirty-seven studies identified through the electronic search were screened for relevance, of which eight were deemed eligible for the meta-analysis ( Figure 1 ).
Excluded studies
Of all identified studies, seven did not measure any ovarian reserve marker and were excluded. Nineteen other studies did not use circulating AMH as an ovarian reserve marker and were excluded. Three further studies were excluded due to missing the mean AE SD AMH data (see Supplementary material, Table S2 ). Authors of these studies were contacted to provide the missing data as explained above. Tables 2 and 3 . 
Included studies

Details of the eight included studies are shown in
Study design
This systematic review included three prospective cohorts (11, 14, 21) , two retrospective cohorts (10,13), one crosssectional study (15) , and two RCTs (9, 12) . In one RCT, the two arms including women undergoing salpingectomy (with and without removal of mesosalpinx) were combined and used as a cohort study for this meta-analysis (12) . In the other RCT comparing laparoscopic hysterectomy with and without bilateral salpingectomy, the salpingectomy arm was used as a cohort study and included in our meta-analysis (9).
Participants
In four studies, participants had normal fallopian tubes, which were removed during a gynecological procedure including hysterectomy (9,10,21), myomectomy or sterilization (12) . In three other studies, participants underwent salpingectomy due to tubal ectopic pregnancy (11, 14, 15) . In the remaining study, women underwent salpingectomy due to tubal pathology including tubo-ovarian abscess, ectopic pregnancy or hydro-salpinx (13) .
All studies stated inclusion and exclusion criteria, which were appropriate, except for one study, which was a conference abstract (11) . We successfully obtained missing data after contacting the author of this study.
Salpingectomy surgery
All participants underwent salpingectomy through laparoscopy except in two studies, which included women undergoing salpingectomy through laparotomy or laparoscopy (15, 21) . All studies specified the laterality of salpingectomy, which was bilateral in four studies (9, 10, 12, 21) and unilateral in three studies (11, 14, 15) . The remaining study compared unilateral and bilateral salpingectomy (13) . Both unilateral and bilateral arms were combined and used in the initial analysis. Each arm was then used separately in the sub-analysis (13). Findley et al. tended to preserve the mesosalpinx during salpingectomy (9). Venturella et al. compared salpingectomy with preservation of mesosalpinx (standard salpingectomy) vs. salpingectomy with removal of mesosalpinx (wide technique salpingectomy) (12) . Six studies did not report whether or not the mesosalpinx was preserved (10, 11, (13) (14) (15) 21) . 
Length of follow up after salpingectomy
The length of follow up after salpingectomy was 3 months in four studies (9, 10, 12, 14) , 4 months in one study (11) , 6 months in one study (21) , 18 months in one study (15) , and not specified in one study (13) . One study reported two postoperative measurements at 4-6 weeks and at 3 months (9).
AMH kits
Four kits were used to measure serum AMH levels. The modified AMH Gen II enzyme linked immunosorbent assay (ELISA) (Beckman Coulter, Chaska, MN, USA) was used by four studies (10) (11) (12) 14) . The intra-assay and interassay coefficients of variation for the AMH were both <10%, with a detection limit of 0.08 ng/mL. Two studies used the AMH ELISA Ansh Labs assay (Ansh Labs, Webster, TX, USA) (9, 15) . The intra-assay and inter-assay coefficients of variation for the AMH were 0.02 (2.22/95) and 7.81 (15.62/2), respectively, with a detection limit of 0.06 ng/mL. One study measured AMH by an ELISA using a Bio-Rad iMark microplate absorbance reader with reagent kits from Bio-Rad (Bio-Rad Laboratories Inc, Hercules, CA, USA) (13) . The inter-assay coefficient of variability was 10%, and the intra-assay coefficient of variability was 15%. The remaining study measured AMH using a commercially available ELISA kit (Cusabio Biotech Co., Ltd., Hubei, China). The detection sensitivity of this assay was 0.14 ng/mL and the inter-assay coefficient was 14.2% (21) . AMH values reported in pmol/L were converted to ng/mL using a universally accepted laboratory formula: 1 ng/mL = 7.14 pmol/L (26).
Potential source of bias
In all included studies, recruitment of participants was consecutive. The selection method was clearly defined, rendering it easy to assess selection bias.
Overall pooled results for all studies
Pooled analysis of group 1 studies (n = 464) revealed no statistically significant change in serum AMH levels after salpingectomy (WMD À0.10 ng/mL; 95% CI À0.19 to 0.00, I 2 = 0%) with low heterogeneity between studies ( Figure 2 ) (9) (10) (11) (12) 14, 21) . Similarly, in group 2, overall analysis of two studies showed no statistically significant difference between the salpingectomy group (n = 169) and control group (n = 154) (WMD À0.11 ng/mL; 95% CI À0.37 to 0.14, I 2 = 77%) with high heterogeneity between studies (Figure 3) (13,15) .
Subgroup analysis
Laterality of salpingectomy. In group 1 studies, bilateral salpingectomy was reported in four studies including 383 women (9, 10, 12, 21) . Pooled analysis of these studies showed no statistically significant change in postoperative serum AMH level (WMD À0.10 ng/mL; 95% CI À0.20 to 0.00; I 2 = 0%). Analysis of two studies of unilateral salpingectomy (n = 81) revealed no statistically significant change in serum AMH concentration after surgery (WMD 0.10 ng/mL; 95% CI À0.45 to 0.65; I 2 = 0%) (11, 14) .
In group 2 studies, unilateral salpingectomy was reported in two studies (13, 14) . Pooled analysis showed no statistically significant difference between the salpingectomy group (n = 128) and the control group (n = 154) (WMD À0.11 ng/mL; 95% CI À0.38 to 0.16; I 2 = 79%).
Studies using different AMH assays. In group 1, analysis of four studies (n = 346) using a modified Gen II AMH kit showed no statistically significant changes in AMH concentration after salpingectomy (WMD À0.07 ng/mL; 95% CI À0.17 to 0.04; I 2 = 0%) (10) (11) (12) 14) .
Participants' age. In group 1, pooled analysis of three studies including 96 participants aged <40 years revealed no statistically significant change in serum AMH level (WMD À0.05 ng/mL; 95% CI À0.47 to 0.57; I 2 = 0%) (9, 11, 14) . In group 2 studies, all participants were aged <40 years and a sub-analysis was therefore not performed (13, 15) .
Analysis of three studies in group 1 (n = 368) with participants >40 years also revealed no statistically significant change in serum AMH concentration (WMD À0.10 ng/ mL; 95% CI À0.20 to 0.00; I 2 = 0%) (10, 12, 21) .
Sensitivity analysis
Sensitivity analysis in group 1, included the three studies with participants aged <40 years (n = 96), which were also the studies with low risk of bias. The results of this analysis are shown above. In group 2, only one study scored high in the risk of bias assessment and a sensitivity analysis was therefore not performed (15) .
Secondary outcomes
In group 1, three studies including 368 women measured serum FSH concentrations (10, 12, 21) and two studies (n = 265) measured AFC after salpingectomy (10, 12) . Pooled analysis of these studies revealed a statistically significant increase in circulating FSH (WMD 1.75 IU/L; 95% CI 0.69-2.81; I 2 = 81%), but no significant change in AFC following bilateral salpingectomy (WMD À0.30; 95% CI À0.64 to 0.05; I 2 = 0%). In group 2, two studies measured serum FSH and AFC (13, 15) . Meta-analysis of these studies showed no significant difference in serum FSH levels between salpingectomy (n = 169) and control (n = 154) groups (WMD 0.58 IU/L; 95% CI À0.21 to 1.37; I 2 = 63%). On the other hand, pooled analysis showed a significantly lower AFC in the salpingectomy group compared with the control group (WMD À0.66; 95% CI À1.27 to À0.06; I 2 = 42%).
Discussion
To the best of our knowledge, this is the first systematic review to investigate the impact of salpingectomy on ovarian reserve as determined by circulating AMH. The overall analysis as well as subgroup analysis based on laterality, age and AMH kits revealed no short-term changes in serum AMH concentrations after salpingectomy. These results are surprising given the expected post-salpingectomy damage to ovarian reserve as a result of impairment of ovarian blood supply as shown in several previous studies (5, 6, 13) . Furthermore, it was interesting to see that even wide (radical) and bilateral salpingectomy did not cause any decline in serum AMH concentration despite the expected increase in damage to the ovarian blood supply. Our results are in disagreement with a recent systematic review, which reported post-salpingectomy impairment of ovarian reserve as determined by ovarian response to hyperstimulation during IVF (27) . This discrepancy could be explained by the differences in the methods used to assess ovarian reserve between our meta-analysis (AMH) and the previous systematic review (ovarian response during IVF).
It was also surprising to see that ovarian reserve was not affected after salpingectomy even when performed with hysterectomy despite the loss of an important ovarian blood supply from the utero-ovarian vessels. It may be argued that studies involving hysterectomy should have been excluded from this meta-analysis due to the added element of damage to utero-ovarian vessels. However, we included these studies in order to address a wellrecognized concern over the possible adverse effect of opportunistic salpingectomy during hysterectomy on ovarian reserve. We believe that this is a clinically important issue that will be of interest to gynecological surgeons. Had we found an effect on AMH in the hysterectomy group we would have performed a sub-analysis to exclude studies involving hysterectomy.
Possible explanation for our unexpected results is that the postulated post-salpingectomy decline of ovarian reserve may be a chronic process that could take a long time to occur. In other words, the possible post-salpingectomy impairment of blood supply may lead to chronic ovarian ischemia that could take a relatively long time to cause reduction in the number of the small antral follicles with subsequent fall in circulating AMH, which is exclusively secreted from these follicles. This hypothesis, however, requires validation through further long-term follow-up studies on the changes of circulating AMH after salpingectomy. One recent long-term study revealed no change in circulating AMH up to 5 years after salpingectomy (28) . However, these data are inconclusive due to the relatively old age of all participants (mean age, 44 years) with very low AMH values at baseline.
As far as other ovarian reserve markers are concerned, group 1 analysis revealed a small but statistically significant increase in circulating FSH (WMD 1.75 IU/L). However, given the well-known high inter-cycle and intra-cycle variability of circulating FSH, this small change is unlikely to reflect a real decline in ovarian reserve. Furthermore, serum FSH level is currently considered as an ovarian reserve marker of little clinical value in young women (29) . With regards to the AFC, it was interesting to see (in group 2 meta-analysis) lower values in women undergoing salpingectomy compared with the healthy controls. This is surprising as AFC outcome was expected to be in line with AMH as both correlate well with each other. It is worth mentioning that the larger of the two studies in this analysis included participants with tubal/adnexal pathology, which could have already compromised AFC before surgery. This is supported by the lack of any effect of salpingectomy on AFC in group 1 studies, which included participants with no tubal pathology. However, this does not explain the discrepancy between AFC and AMH outcomes in group 2 meta-analysis. This issue could only be resolved with further studies comparing pre-and post-salpingectomy AFC and circulating AMH in women with and without tubal pathology.
Based on our results, there seems to be no evidence of any short-term compromise to ovarian reserve following salpingectomy. However, these results should be interpreted with caution, given the short duration of follow up in all studies included in this meta-analysis. Furthermore, the lack of any short-term decline in serum AMH levels after salpingectomy does not necessarily mean that the long-term chances of pregnancy are not compromised by this procedure. We therefore recommend that, until further evidence becomes available from long-term follow-up studies, salpingectomy should only be performed when necessary and women should be counseled with regards to the uncertainty regarding risks to ovarian reserve. Alternative conservative approaches may be advisable whenever possible.
The main limitations of this meta-analysis are the very small number of studies included and the short duration of follow up, which make it difficult to draw any objective conclusion on the long-term preservation of ovarian function after surgery. Another important limitation is the variation in the surgical techniques and tubal pathologies in participants of different studies. Furthermore, although circulating AMH is considered the most reliable marker of ovarian reserve, it does not directly measure the total follicle pool. It should therefore be considered a surrogate marker of ovarian reserve and the results should be interpreted with caution.
With regards to the quality and risk of bias assessment of the included studies, it is worth mentioning that all available tests including the Newcastle-Ottawa scale, which is used in this study, are of limited ability when the number of included studies is small.
In conclusion, salpingectomy seems to have no shortterm adverse effect on ovarian reserve. However, given the possible concomitant damage to ovarian blood supply during salpingectomy, long-term adverse effect on ovarian reserve remains a concern that requires further investigations.
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